ArticleFrontiers in cardiovascular medicine2026
Global burden and trend of ischemic heart disease and its attributable risk factors among women of childbearing age from 1990 to 2021.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut microbiota-derived metabolites in cardiovascular disease: mechanisms, disease-specific roles, and translational opportunities.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the burden and trends of ischemic heart disease (IHD) and the risk-attributable fractions in women of childbearing age (WCBA) from 1990 to 2021 across 204 countries and territories. Methods: Data on the number and crude rates of incidence, mortality, disability-adjusted life years (DALYs), and the proportion attributable to risk factors were obtained from the Global Burden of Disease Study 2021. Temporal trends were assessed by calculating the estimated annual percentage change in age-standardized rate. Results: In 2021, there were 1,349,518 [95% uncertainty interval (UI), 924,620-1,849,024] new cases of IHD among WCBA, resulting in 172,204 (95% UI, 157,564-188,669) deaths and 8,712,835 (95% UI, 7,995,218-9,531,167) DALYs globally. From 1990 to 2021, the age-standardized incidence rate increased by a slight annual change of 0.4%, while the age-standardized mortality and DALY rates declined by 1.04% and 1.02% annually, respectively. Regional analysis revealed the highest IHD burden in North Africa and the Middle East, while Oceania reported the highest mortality-to-incidence ratio. While the age-standardized mortality and DALYs rates of IHD have shown a declining trend in low- and middle-SDI regions, the absolute numbers of deaths and DALYs have risen substantially. Attributable risks, including poor diet, tobacco use, high body mass index, and high blood pressure, were major contributors to IHD-related deaths and DALYs. Notably, the proportion of IHD attributable to high BMI and high blood pressure has increased, particularly in higher-SDI regions. Conclusions: The burden of IHD among WCBA is rising globally, with significant regional disparities and increasing attributable risks, particularly in low- and middle-SDI regions. These findings highlight the urgent need for targeted, gender-responsive policies and preventive strategies that address modifiable risk factors, strengthen primary healthcare systems, and prioritize cardiovascular health across the life course.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.